Psychotherapies have long-term benefit for those suffering from irritable bowel syndrome

December 28, 2015

For some time doctors have known that psychological therapies can reduce the symptoms of irritable bowel syndrome in the short term.

IBS is a gastrointestinal disorder that affects 7 - 16 percent of the U.S. population, adding somewhere between $950 million to $1.35 billion annually to the nation's healthcare bill.

A new meta-analysis, published online on Dec. 22, 2015 by the journal Clinical Gastroenterology and Hepatology, has now found that the beneficial effects of psychological therapy also appear to last at least six to 12 months after the therapy has concluded. The study analyzed the results of 41 clinical trials from a number of different countries containing more than 2,200 patients.

"Our study is the first one that has looked at long-term effects," said senior author Lynn S. Walker, professor of pediatrics at Vanderbilt University Medical Center. "We found that the moderate benefit that psychological therapies confer in the short term continue over the long term. This is significant because IBS is a chronic, intermittent condition for which there is no good medical treatment."

IBS, which is characterized by chronic abdominal pain, discomfort, bloating, diarrhea or constipation, is classified as a disorder of the "brain-gut axis." Although no cure is known, there are treatments to relieve symptoms including dietary adjustments, medication and psychological interventions.

"Western medicine often conceptualizes the mind as separate from the body, but IBS is a perfect example of how the two are connected," said first author Kelsey Laird, a doctoral student in Vanderbilt's clinical psychology program. "Gastrointestinal symptoms can increase stress and anxiety, which can increase the severity of the symptoms. This is a vicious cycle that psychological treatment can help break."

The studies that Laird analyzed included a number of different types of psychological therapies, including cognitive therapies, relaxation and hypnosis. Her analysis found no significant difference in the effectiveness of different types of psychotherapy. It also found that the length of the treatment (the number of sessions) didn't matter.

Possibly most significant from a healthcare cost perspective was the finding that treatments conducted online appear to be equally as effective as those conducted in person.

"In this study we looked at the effect of psychological therapies on gastrointestinal symptoms. In a follow-up study I am investigating the effect that they have on patients' ability to function: go to work, go to school, participate in social activities and so on," Laird said.
-end-
Paper co-authors are Research Assistant Professor Emily Tanner-Smith at the Peabody Research Institute, clinical fellow Alexandra Russell in Pediatrics and Gertrude Conaway Professor of Psychology Steven Hollon.

Vanderbilt University

Related Irritable Bowel Syndrome Articles from Brightsurf:

Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

Mindfulness program may benefit patients with irritable bowel syndrome
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress.

The Lancet Gasteroenterology & Hepatology: First clinical trial finds probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome
Probiotic bacteria that have been killed by heat can significantly improve symptoms of irritable bowel syndrome (IBS) compared to placebo, and are not associated with any safety risk, according to a new 12-week, randomized, double-blind, placebo-controlled clinical trial with 443 patients published in The Lancet Gastroenterology & Hepatology journal.

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

New, noninvasive test for bowel diseases
Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialized countries.

HKBU discovers mechanisms underlying early life stress and irritable bowel syndrome
Researchers from Hong Kong Baptist University have found that the abnormal rise of a soluble protein called Nerve Growth Factor is a key factor linking early life stress to the development of irritable bowel syndrome.

Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome
To improve the treatment of children with irritable bowel syndrome (IBS), investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Early source of irritable bowel syndrome discovered
Michigan State University scientists have identified an early cause of intestinal inflammation, one of the first stages of inflammatory bowel disease and irritable bowel syndrome, which afflict around 11 percent of the world's population.

Read More: Irritable Bowel Syndrome News and Irritable Bowel Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.